Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
This intro covers the worst drawdowns seen in SP 500 index funds, explaining factors behind steep declines and the recovery path.
15,257 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A disciplined income plan built around a $750,000 portfolio can generate reliable cash flow, potentially exceeding to...
IonQ and D-Wave fell more than 5% last week as investors tempered bets on quantum stocks amid broader market strength...
If you're wondering should bitcoin while it's under 69K, you’re not alone. This guide breaks down the risks, the math...
Investors brace for a potential 2026 stock market crash as volatility rises. Three defensive ETFs offer ballast with ...
When the world's biggest ethereum treasury buys the dip, it grabs headlines—and raises questions for everyday investo...
Bitcoin climbed back above the $71,000 mark as traders shrugged off regional tensions and pushed higher. The move sig...
A new tech-specific volatility metric is approaching its highest level in two decades, underscoring rising nerves aro...
In March, the stock market today shows AI headlines driving trades. This article breaks down what moved markets, why ...
As volatility returns and a new decade unfolds, experts warn the retirement rule could fail if markets echo the 2000s...
A single number points toward Bitcoin’s potential upside over the long run. This guide breaks down how a real-world a...
Bitcoin slid under $60,000 this week, sparking a wave of liquidations and shifting bets toward a Federal Reserve hike...